WebJan 27, 2016 · Blend Therapeutics, today announced that it has secured $38 million in Series C financing and announced the change of its name to Tarveda Therapeutics, … WebBlend Therapeutics, Inc. recently announced it has secured a $16-million Series B financing. Blend is pioneering an integrative model for discovering novel molecular …
Blend Therapeutics Launches with VC Capital
WebCend Therapeutics Inc. is a biopharmaceutical company dedicated to developing next generation cancer therapies that are designed to overcome the barriers of drug delivery to solid tumors. The novel drug delivery platform works highly specifically in cancer tissues, thereby having the potential to maximize efficacy while minimizing the toxicity ... WebIt synchronizes extended duration caffeine release with a potent antioxidant blend to potentially reduce inflammation & oxidative stress the brain is … scrapbooking spider stickers
NTFactor
WebFEATURED PRODUCTS. The purest form of our patented NTFactor® Lipids in an easily usable powder. Decreases allergic reactions* and relieves sinus congestion.*. Multivitamin, multimineral formula with … WebRole The Medical Science Liaison (MSL) is a field-based regional Medical Affairs professional. Responsibilities include providing medical and scientific education and … WebApr 11, 2015 · Blend Therapeutics Inc., which is preparing to move its first two cancer therapies into clinical trials, said it has named former Clinical Data Inc. Chief Executive … scrapbooking spray adhesive